Evidence map›Paper›PMID 30547757›Full record

ArticleBMC genetics2018

Associations of sex hormone-binding globulin and testosterone with genome-wide DNA methylation.

Ryan Arathimos, Gemma C Sharp, Raquel Granell, Kate Tilling, Caroline L Relton

Open access · diamondAbstract read
In one paragraph

Article in BMC genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. The association between blood-basedLung cancer management · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ryan ArathimosPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. ryan.arathimos@bristol.ac.uk.ORCID 0000-0002-0473-500X
Gemma C SharpMedical Research Council Integrative Epidemiology Unit, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK.
Raquel GranellPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Kate TillingPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Caroline L ReltonPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
University of Bristol · GBBristol City Council · GBUniversity Of Bristol Dental Hospital · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I025263/1Biotechnology and Biological Sciences Research Council BB/I025751/1Medical Research Council G9815508Medical Research Council MC_UU_00011/3Medical Research Council MC_UU_00011/5Wellcome TrustWellcome Trust 102215/2/13/2
6 · The paper itself

Abstract

backgroundLevels of sex hormone-binding globulin (SHBG) and the androgen testosterone have been associated with risk of diseases throughout the lifecourse. Although both SHBG and testosterone have been shown to be highly heritable, only a fraction of that heritability has been explained by genetic studies. Epigenetic modifications such as DNA methylation may explain some of the missing heritability and could potentially inform biological knowledge of endocrine disease mechanisms involved in development of later life disease. Using data from the Avon Longitudinal Study of Parents and Children (ALSPAC), we explored cross-sectional associations of SHBG, total testosterone and bioavailable testosterone in childhood (males only) and adolescence (both males and females) with genome-wide DNA methylation. We also report associations of a SHBG polymorphism (rs12150660) with DNA methylation, which leads to differential levels of SHBG in carriers, as a genetic proxy of circulating SHBG levels.

resultsWe identified several novel sites and genomic regions where levels of SHBG, total testosterone, and bioavailable testosterone were associated with DNA methylation, including one region associated with total testosterone in males (annotated to the KLHL31 gene) in both childhood and adolescence and a second region associated with bioavailable testosterone (annotated to the CMYA5 gene) at both time-points. We also identified one region where both SHBG and bioavailable testosterone in males in childhood (annotated to the ZNF718 gene) was associated with DNA methylation.

conclusionOur findings have important implications in the understanding of the biological processes of SHBG and testosterone, with the potential for future work to determine the molecular mechanisms that could underpin these associations.

Indexed as

DNA MethylationAdolescentChildEpigenomicsFemaleGenotypeHumansLinear ModelsLongitudinal StudiesMalePolymorphism, Single NucleotideSex Hormone-Binding GlobulinTestosteroneSex Hormone-Binding GlobulinTestosteroneALSPACDNA methylationEpigeneticsSex hormonesSHBGTestosterone

Identifiers

PMID30547757
PMCPMC6295101
OpenAlexW2903931012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.